Prakt. Lékáren. 2016; 12(2e) [Pediatr. praxi. 2015;16(3):146-149]

What is new in pediatric diabetology?

doc. MUDr. Štěpánka Průhová, Ph.D., MUDr. Barbora Obermannová, Ph.D.
Pediatrická klinika 2. lékařské fakulty UK a Fakultní Nemocnice Motol v Praze

Research in pediatric diabetology brings some news useful in clinical practice. That includes wilder use of insulin analogues, flexibleinsulin dosing system according to the needs of pediatric patients, the possibility of continuous glucose monitoring connected to theinsulin pump and changing in some dietary recommendations. This article summarizes the current realistic treatment options for pediatricpatients with diabetes in the Czech Republic.

Keywords: type 1 diabetes, insulin analogs, flexible insulin dosing system, closed-loop system, sensor-augmented pump

Published: May 1, 2016  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Průhová Š, Obermannová B. What is new in pediatric diabetology? Praktické lékárenství. 2016;12(E-verze 2/16):.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Danne T, Bangstad H-J, Deeb L, at al. ISPAD Clinical Practice Consensus Guidelines 2014 Compendium Insulin treatment in children and adolescents with diabetes Pediatric Diabetes 2014; 15(Suppl. 20): 115-134. Go to original source... Go to PubMed...
    2. Hamann A, Matthaei S, Rosak C, Silvestre L. A randomized clinical trial comparing breakfast, dinner, or bedtime administration of insulin glargine in patients with type 1 diabetes. Diabetes Care 2003; 26: 1738-1744. Go to original source... Go to PubMed...
    3. Česká diabetologická společnost. Doporučený postup péče o nemocné s diabetem 1. typu. DMEV 2012; 15(1): 8-11.
    4. Rewers MJ, Pillay K, de Beaufort C, at al. Assessment and monitoring of glycemic control in children and adolescents with diabetes. Pediatric Diabetes 2014; 15(Suppl. 20): 102-114. Go to original source... Go to PubMed...
    5. Blackman SM, Raghinaru D, Adi S, et al. Insulin pump use in young children in the T1D Exchange clinic registry is associated with lower hemoglobin A1c levels than injection therapy. Pediatric Diabetes 2014; 15: 564-572. Go to original source... Go to PubMed...
    6. Enander R, Gundevall C, Stromgren A, at al. Carbohydrate counting with a bolus calculator improves post-prandial blood glucose levels in children and adolescents with type 1 diabetes using insulin pumps. Pediatr Diabetes 2012; 13: 545-551. Go to original source... Go to PubMed...
    7. Phillip M, Battelino T, Atlas E, at al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med 2013; 368(9): 824-833. Go to original source... Go to PubMed...
    8. Hovorka R, Elleri D, Thabit H, et al. Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial. Diabetes Care 2014; 37: 1204-1211. Go to original source... Go to PubMed...
    9. Elleri D, Allen JM, Kumareswaran K, et al. Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial. Diabetes Care 2013; 36: 838-844. Go to original source... Go to PubMed...
    10. Peyrot M, Rubin RR, Group SS. Treatment satisfaction in the sensor-augmented pump therapy for A1C reduction 3 (STAR 3) trial. DiabetMed 2013; 30: 464-467. Go to original source... Go to PubMed...
    11. Buse JB, Kudva YC, Battelino T at al. Effects of sensor-augmented pump therapy on glycemic variability in well-controlled type 1 diabetes in the STAR 3 study. Diabetes Technol Ther 2012; 14: 644-647. Go to original source... Go to PubMed...
    12. Smart CE, Evans M, O'Connell SM, at al. Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive. Diabetes Care 2013; 36(12): 3897-902. Go to original source... Go to PubMed...

    Return to the content


    Pharmacy for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.